Form 8-K - Current report:
SEC Accession No. 0000950170-25-101624
Filing Date
2025-08-04
Accepted
2025-08-04 07:43:21
Documents
58
Period of Report
2025-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20250804.htm   iXBRL 8-K 50200
2 EX-99.1 axsm-ex99_1.htm EX-99.1 299347
3 EX-99.2 axsm-ex99_2.htm EX-99.2 44582
4 GRAPHIC img36028404_0.jpg GRAPHIC 66512
5 GRAPHIC axsm-ex99_2s1.jpg GRAPHIC 160241
6 GRAPHIC axsm-ex99_2s2.jpg GRAPHIC 929039
7 GRAPHIC axsm-ex99_2s3.jpg GRAPHIC 245463
8 GRAPHIC axsm-ex99_2s4.jpg GRAPHIC 410311
9 GRAPHIC axsm-ex99_2s5.jpg GRAPHIC 299744
10 GRAPHIC axsm-ex99_2s6.jpg GRAPHIC 221023
11 GRAPHIC axsm-ex99_2s7.jpg GRAPHIC 354117
12 GRAPHIC axsm-ex99_2s8.jpg GRAPHIC 303620
13 GRAPHIC axsm-ex99_2s9.jpg GRAPHIC 330620
14 GRAPHIC axsm-ex99_2s10.jpg GRAPHIC 360001
15 GRAPHIC axsm-ex99_2s11.jpg GRAPHIC 277554
16 GRAPHIC axsm-ex99_2s12.jpg GRAPHIC 257953
17 GRAPHIC axsm-ex99_2s13.jpg GRAPHIC 235626
18 GRAPHIC axsm-ex99_2s14.jpg GRAPHIC 246168
19 GRAPHIC axsm-ex99_2s15.jpg GRAPHIC 325045
20 GRAPHIC axsm-ex99_2s16.jpg GRAPHIC 332061
21 GRAPHIC axsm-ex99_2s17.jpg GRAPHIC 261249
22 GRAPHIC axsm-ex99_2s18.jpg GRAPHIC 342775
23 GRAPHIC axsm-ex99_2s19.jpg GRAPHIC 339505
24 GRAPHIC axsm-ex99_2s20.jpg GRAPHIC 270137
25 GRAPHIC axsm-ex99_2s21.jpg GRAPHIC 324748
26 GRAPHIC axsm-ex99_2s22.jpg GRAPHIC 348154
27 GRAPHIC axsm-ex99_2s23.jpg GRAPHIC 208285
28 GRAPHIC axsm-ex99_2s24.jpg GRAPHIC 384834
29 GRAPHIC axsm-ex99_2s25.jpg GRAPHIC 292576
30 GRAPHIC axsm-ex99_2s26.jpg GRAPHIC 314943
31 GRAPHIC axsm-ex99_2s27.jpg GRAPHIC 278276
32 GRAPHIC axsm-ex99_2s28.jpg GRAPHIC 375419
33 GRAPHIC axsm-ex99_2s29.jpg GRAPHIC 336444
34 GRAPHIC axsm-ex99_2s30.jpg GRAPHIC 287244
35 GRAPHIC axsm-ex99_2s31.jpg GRAPHIC 393410
36 GRAPHIC axsm-ex99_2s32.jpg GRAPHIC 309787
37 GRAPHIC axsm-ex99_2s33.jpg GRAPHIC 312712
38 GRAPHIC axsm-ex99_2s34.jpg GRAPHIC 373542
39 GRAPHIC axsm-ex99_2s35.jpg GRAPHIC 331099
40 GRAPHIC axsm-ex99_2s36.jpg GRAPHIC 266773
41 GRAPHIC axsm-ex99_2s37.jpg GRAPHIC 377803
42 GRAPHIC axsm-ex99_2s38.jpg GRAPHIC 260754
43 GRAPHIC axsm-ex99_2s39.jpg GRAPHIC 274455
44 GRAPHIC axsm-ex99_2s40.jpg GRAPHIC 342275
45 GRAPHIC axsm-ex99_2s41.jpg GRAPHIC 287920
46 GRAPHIC axsm-ex99_2s42.jpg GRAPHIC 348696
47 GRAPHIC axsm-ex99_2s43.jpg GRAPHIC 340000
48 GRAPHIC axsm-ex99_2s44.jpg GRAPHIC 318269
49 GRAPHIC axsm-ex99_2s45.jpg GRAPHIC 110873
  Complete submission text file 0000950170-25-101624.txt   20316320

Data Files

Seq Description Document Type Size
50 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20250804.xsd EX-101.SCH 23858
60 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20250804_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 251178035
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)